Publication | Open Access

Validation of the Proteasome as a Therapeutic Target in Plasmodium Using an Epoxyketone Inhibitor with Parasite-Specific Toxicity

Medicinal ChemistryBiochemistryAntiparasitic AgentMedicineNatural SciencesProteomicsMalariaParasite-specific ToxicityParasite ControlEpoxyketone InhibitorAnti-cancer AgentPharmacologyDrug Discovery